Advertisement

Pharmacokinetics of S-ketamine and R-ketamine and their active metabolites after racemic ketamine or S-ketamine intravenous administration in dogs sedated with medetomidine

Published:November 06, 2019DOI:https://doi.org/10.1016/j.vaa.2019.08.048

      Abstract

      Objective

      To assess the differences in the pharmacokinetic profiles of S-ketamine, R-ketamine and their metabolites, S-norketamine and R-norketamine, and to measure relevant physiologic variables after intravenous administration of racemic (RS) ketamine or S-ketamine alone in Beagle dogs sedated with medetomidine.

      Study design

      Experimental, blinded and randomized crossover study.

      Animals

      A total of six (three female and three male) adult Beagle dogs.

      Methods

      Medetomidine (450 μg m–2) was administered intramuscularly, followed by either S-ketamine (2 mg kg–1) or RS-ketamine (4 mg kg–1) 20 minutes later, both administered intravenously. Blood samples were collected before medetomidine administration and at multiple time points 1–900 minutes following the ketamine administration. Plasma samples were analysed using liquid chromatography–tandem mass spectrometry. Heart rate, respiratory rate, noninvasive blood pressure, haemoglobin saturation with oxygen and body temperature were measured at baseline, before ketamine administration, and 1, 2, 5, 10, 15, 20 and 30 minutes after ketamine administration. All cardiovascular variables, blood glucose, haemoglobin and lactate concentrations were analysed using different linear mixed effects models; the significance was set at p < 0.05.

      Results

      S-ketamine showed a two-compartment kinetic profile; no statistically significant differences were observed between its concentrations or in the calculated pharmacokinetic parameters following S- or RS-ketamine. When the racemic mixture was administered, no differences were detected between R- and S-ketamine concentrations, but the area under the curve (AUC) for R-norketamine was significantly lower than that for S-norketamine. Clinically relevant physiologic variables did not show statistically significant differences following the administration of the racemic mixture or of S-ketamine alone.

      Conclusions and clinical relevance

      This study performed in dogs showed that RS-ketamine and S-ketamine combined with medetomidine showed enantioselective pharmacokinetics as S- and R-norketamine AUCs were different, but S-ketamine levels were identical.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Veterinary Anaesthesia and Analgesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bergman S.A.
        Ketamine: review of its pharmacology and its use in pediatric anesthesia.
        Anesth Prog. 1999; 46: 10-20
        • Capponi L.
        • Schmitz A.
        • Thormann W.
        • et al.
        In vitro evaluation of differences in phase 1 metabolism of ketamine and other analgesics among humans, horses, and dogs.
        Am J Vet Res. 2009; 70: 77-86
        • Doenicke A.
        • Kugler J.
        • Mayer M.
        • et al.
        Ketamine racemate or S-(+)-ketamine and midazolam. The effect on vigilance, efficacy and subjective findings.
        Anaesthesist. 1992; 41: 610-618
        • Duhamel M.C.
        • Troncy E.
        • Beaudry F.
        Metabolic stability and determination of cytochrome P450 isoenzymes' contribution to the metabolism of medetomidine in dog liver microsomes.
        Biomed Chromatogr. 2010; 24: 868-877
        • Duque J.C.
        • Oleskovicz N.
        • Guirro E.C.
        • et al.
        Relative potency of ketamine and S(+)-ketamine in dogs.
        J Vet Pharmacol Ther. 2008; 31: 344-348
        • Enouri S.S.
        • Kerr C.L.
        • McDonell W.N.
        • Dyson D.H.
        Cardiopulmonary effects of anesthetic induction with thiopental, propofol, or a combination of ketamine hydrochloride and diazepam in dogs sedated with a combination of medetomidine and hydromorphone.
        Am J Vet Res. 2008; 69: 586-595
        • Filzek U.
        • Fischer U.
        • Ferguson J.
        • et al.
        Injektionsnarkosen beim Pferd-Ketaminrazemat versus S-(+)-Ketamin bei 20 Pferden unter Klinikbedingungen.
        Pferdeheilkunde. 2003; 19: 501-506
        • Flecknell P.A.
        Anaesthesia of animals for biomedical research.
        Br J Anaest. 1993; 71: 885-894
        • Holtman Jr., J.R.
        • Crooks P.A.
        • Johnson-Hardy J.K.
        • et al.
        Effects of norketamine enantiomers in rodent models of persistent pain.
        Pharmacol Biochem Behav. 2008; 90: 676-685
        • Ihmsen H.
        • Geisslinger G.
        • Schüttler J.
        Stereoselective pharmacokinetics of ketamine: R(−)-Ketamine inhibits the elimination of S(+)-ketamine.
        Clin Pharmcol Ther. 2001; 70: 431-438
        • Kharasch E.D.
        • Hill H.F.
        • Eddy A.C.
        Influence of dexmedetomidine and clonidine on human liver microsomal alfentanil metabolism.
        Anesthesiology. 1991; 75: 520-524
        • Kharasch E.D.
        • Herrmann S.
        • Labroo R.
        Ketamine as a probe for medetomidine stereoisomer inhibition of human liver microsomal drug metabolism.
        Anesthesiology. 1992; 77: 1208-1214
        • Ko J.C.
        • Fox S.M.
        • Mandsager R.E.
        Anesthetic effects of ketamine or isoflurane induction prior to isoflurane anesthesia in medetomidine-premedicated dogs.
        J Am Anim Hosp Assoc. 2001; 37: 411-419
        • Larenza M.P.
        • Landoni M.F.
        • Levionnois O.L.
        • et al.
        Stereoselective pharmacokinetics of ketamine and norketamine after racemic ketamine or S-ketamine administration during isoflurane anaesthesia in Shetland ponies.
        Br J Anaesth. 2007; 98: 204-212
        • Larenza M.P.
        • Knobloch M.
        • Landoni M.F.
        • et al.
        Stereoselective pharmacokinetics of ketamine and norketamine after racemic ketamine or S-ketamine administration in Shetland ponies sedated with xylazine.
        Vet J. 2008; 177: 432-435
        • Larenza M.P.
        • Peterbauer C.
        • Landoni M.F.
        • et al.
        Stereoselective pharmacokinetics of ketamine and norketamine after constant rate infusion of a subanesthetic dose of racemic ketamine or S-ketamine in Shetland ponies.
        Am J Vet Res. 2009; 70: 831-839
        • Lawrence C.J.
        • Prinzen F.W.
        • de Lange S.
        The effect of dexmedetomidine on nutrient organ blood flow.
        Anesth Analg. 1996; 83: 1160-1165
        • Pinheiro J.
        • Bates D.
        • DebRoy S.
        • et al.
        nlme: Linear and Nonlinear Mixed Effects Models_.
        (R package version 3.1-137)
        • Pypendop B.H.
        • Verstegen J.P.
        Hemodynamic effects of medetomidine in the dog: a dose titration study.
        Vet Surg. 1998; 27: 612-622
        • R Core Team
        R: a language and environment for statistical computing.
        R Foundation for Statistical Computing. 2018;
        • Restitutti F.
        • Laitinen M.R.
        • Raekallio M.R.
        • et al.
        Effect of MK-467 on organ blood flow parameters detected by contrast-enhanced ultrasound in dogs treated with dexmedetomidine.
        Vet Anaesth Analg. 2013; 40: e48-e60
        • Romagnoli N.
        • Bektas R.N.
        • Kutter A.P.
        • et al.
        Pharmacokinetics of ketamine and norketamine enantiomers after racemic or S-ketamine IV bolus administration in dogs during sevoflurane anaesthesia.
        Res Vet Sci. 2017; 112: 208-213
        • Sandbaumhüter F.A.
        • Theurillat R.
        • Thormann W.
        Effects of medetomidine and its active enantiomer dexmedetomidine on N-demethylation of ketamine in canines determined in vitro using enantioselective capillary electrophoresis.
        Electrophoresis. 2015; 36: 2703-2712
        • Sandbaumhüter F.A.
        • Theurillat R.
        • Bektas R.N.
        • et al.
        Pharmacokinetics of ketamine and three metabolites in Beagle dogs under sevoflurane vs. medetomidine comedication assessed by enantioselective capillary electrophoresis.
        J Chromatogr A. 2016; 1467: 436-444
        • Schmitz A.
        • Thormann W.
        • Moessner L.
        • et al.
        Enantioselective CE analysis of hepatic ketamine metabolism in different species in vitro.
        Electrophoresis. 2010; 31: 1506-1516
        • Stekhoven D.J.
        missForest: Nonparametric Missing Value Imputation using Random Forest.
        2013 (R package version 1.4)
        • Ueyema Y.
        • Waselau A.C.
        • Wiese A.J.
        • Muir W.W.
        Anesthetic and cardiopulmonary effects of intramuscular morphine, medetomidine, ketamine injection in dogs.
        Vet Anaesth Analg. 2008; 35: 480-487
        • Yamaoka K.
        • Nakagawa T.
        • Uno T.
        Application of Akaike’s information criterion (AIC) in the evaluation of linear pharmacokinetic equations.
        J Pharmacokinet Biopharm. 1978; 6: 165-175
        • Zeileis A.
        • Hothorn T.
        Diagnostic checking in regression relationships.
        R News. 2002; 2: 7-10